The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801: Possible implications for psychosis

Kevin Carter, Jon Dickerson, Darryle D. Schoepp, Melinda Reilly, Nicole Herring, Jon Williams, Floyd R. Sallee, James W. Sharp, Frank R Sharp

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The non-competitive NMDA receptor antagonists, including PCP (phencyclidine), ketamine, and MK-801 (dizocilpine) produce psychosis in humans and injure neurons in retrosplenial cortex in adult rodent brain. This study examined the effects of the metabotropic mGlu2/3 agonist LY379268 and antagonist LY341495 on cortical injury produced by systemic MK-801 (1 mg/kg i.p.) in adult female rats. Systemic injections of mGlu2/3 agonist LY379268, but not mGlu2/3 antagonist LY341495, decreased the injury in the retrosplenial cortex produced by systemic MK-801 as assessed by Hsp70 induction. Bilateral injections of LY379268, but not vehicle, into retrosplenial cortex or bilateral injections of LY379268 into anterior thalamus also decreased the injury in retrosplenial cortex produced by systemic MK-801. The data show that bilateral activation of mGlu2/3 glutamate receptors in cortex or anterior thalamus decreases the neuronal injury in retrosplenial cortex produced by systemic MK-801. Because antipsychotic medications decrease cortical injury produced by NMDA antagonists in rodents and decrease psychosis in humans, mGlu2/3 agonists that decrease cortical injury produced by NMDA antagonists in rodents might be evaluated for decreasing psychosis in people.

Original languageEnglish (US)
Pages (from-to)1135-1145
Number of pages11
JournalNeuropharmacology
Volume47
Issue number8
DOIs
StatePublished - Dec 2004

Fingerprint

LY 379268
Dizocilpine Maleate
N-Methyl-D-Aspartate Receptors
Thalamus
Psychotic Disorders
LY 341495
Wounds and Injuries
Anterior Thalamic Nuclei
Rodentia
N-Methylaspartate
Injections
Phencyclidine
Glutamate Receptors
Ketamine
Antipsychotic Agents
Neurons
Brain

Keywords

  • G-protein coupled receptors
  • Glutamate receptors
  • Ketamine
  • Metabotropic glutamate receptors
  • NMDA receptors
  • Phencyclidine
  • Psychomimetics
  • Schizophrenia

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Drug Discovery
  • Pharmacology

Cite this

The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801 : Possible implications for psychosis. / Carter, Kevin; Dickerson, Jon; Schoepp, Darryle D.; Reilly, Melinda; Herring, Nicole; Williams, Jon; Sallee, Floyd R.; Sharp, James W.; Sharp, Frank R.

In: Neuropharmacology, Vol. 47, No. 8, 12.2004, p. 1135-1145.

Research output: Contribution to journalArticle

Carter, Kevin ; Dickerson, Jon ; Schoepp, Darryle D. ; Reilly, Melinda ; Herring, Nicole ; Williams, Jon ; Sallee, Floyd R. ; Sharp, James W. ; Sharp, Frank R. / The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801 : Possible implications for psychosis. In: Neuropharmacology. 2004 ; Vol. 47, No. 8. pp. 1135-1145.
@article{9651457614694b0bbfa90c9aa5b2be38,
title = "The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801: Possible implications for psychosis",
abstract = "The non-competitive NMDA receptor antagonists, including PCP (phencyclidine), ketamine, and MK-801 (dizocilpine) produce psychosis in humans and injure neurons in retrosplenial cortex in adult rodent brain. This study examined the effects of the metabotropic mGlu2/3 agonist LY379268 and antagonist LY341495 on cortical injury produced by systemic MK-801 (1 mg/kg i.p.) in adult female rats. Systemic injections of mGlu2/3 agonist LY379268, but not mGlu2/3 antagonist LY341495, decreased the injury in the retrosplenial cortex produced by systemic MK-801 as assessed by Hsp70 induction. Bilateral injections of LY379268, but not vehicle, into retrosplenial cortex or bilateral injections of LY379268 into anterior thalamus also decreased the injury in retrosplenial cortex produced by systemic MK-801. The data show that bilateral activation of mGlu2/3 glutamate receptors in cortex or anterior thalamus decreases the neuronal injury in retrosplenial cortex produced by systemic MK-801. Because antipsychotic medications decrease cortical injury produced by NMDA antagonists in rodents and decrease psychosis in humans, mGlu2/3 agonists that decrease cortical injury produced by NMDA antagonists in rodents might be evaluated for decreasing psychosis in people.",
keywords = "G-protein coupled receptors, Glutamate receptors, Ketamine, Metabotropic glutamate receptors, NMDA receptors, Phencyclidine, Psychomimetics, Schizophrenia",
author = "Kevin Carter and Jon Dickerson and Schoepp, {Darryle D.} and Melinda Reilly and Nicole Herring and Jon Williams and Sallee, {Floyd R.} and Sharp, {James W.} and Sharp, {Frank R}",
year = "2004",
month = "12",
doi = "10.1016/j.neuropharm.2004.08.018",
language = "English (US)",
volume = "47",
pages = "1135--1145",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801

T2 - Possible implications for psychosis

AU - Carter, Kevin

AU - Dickerson, Jon

AU - Schoepp, Darryle D.

AU - Reilly, Melinda

AU - Herring, Nicole

AU - Williams, Jon

AU - Sallee, Floyd R.

AU - Sharp, James W.

AU - Sharp, Frank R

PY - 2004/12

Y1 - 2004/12

N2 - The non-competitive NMDA receptor antagonists, including PCP (phencyclidine), ketamine, and MK-801 (dizocilpine) produce psychosis in humans and injure neurons in retrosplenial cortex in adult rodent brain. This study examined the effects of the metabotropic mGlu2/3 agonist LY379268 and antagonist LY341495 on cortical injury produced by systemic MK-801 (1 mg/kg i.p.) in adult female rats. Systemic injections of mGlu2/3 agonist LY379268, but not mGlu2/3 antagonist LY341495, decreased the injury in the retrosplenial cortex produced by systemic MK-801 as assessed by Hsp70 induction. Bilateral injections of LY379268, but not vehicle, into retrosplenial cortex or bilateral injections of LY379268 into anterior thalamus also decreased the injury in retrosplenial cortex produced by systemic MK-801. The data show that bilateral activation of mGlu2/3 glutamate receptors in cortex or anterior thalamus decreases the neuronal injury in retrosplenial cortex produced by systemic MK-801. Because antipsychotic medications decrease cortical injury produced by NMDA antagonists in rodents and decrease psychosis in humans, mGlu2/3 agonists that decrease cortical injury produced by NMDA antagonists in rodents might be evaluated for decreasing psychosis in people.

AB - The non-competitive NMDA receptor antagonists, including PCP (phencyclidine), ketamine, and MK-801 (dizocilpine) produce psychosis in humans and injure neurons in retrosplenial cortex in adult rodent brain. This study examined the effects of the metabotropic mGlu2/3 agonist LY379268 and antagonist LY341495 on cortical injury produced by systemic MK-801 (1 mg/kg i.p.) in adult female rats. Systemic injections of mGlu2/3 agonist LY379268, but not mGlu2/3 antagonist LY341495, decreased the injury in the retrosplenial cortex produced by systemic MK-801 as assessed by Hsp70 induction. Bilateral injections of LY379268, but not vehicle, into retrosplenial cortex or bilateral injections of LY379268 into anterior thalamus also decreased the injury in retrosplenial cortex produced by systemic MK-801. The data show that bilateral activation of mGlu2/3 glutamate receptors in cortex or anterior thalamus decreases the neuronal injury in retrosplenial cortex produced by systemic MK-801. Because antipsychotic medications decrease cortical injury produced by NMDA antagonists in rodents and decrease psychosis in humans, mGlu2/3 agonists that decrease cortical injury produced by NMDA antagonists in rodents might be evaluated for decreasing psychosis in people.

KW - G-protein coupled receptors

KW - Glutamate receptors

KW - Ketamine

KW - Metabotropic glutamate receptors

KW - NMDA receptors

KW - Phencyclidine

KW - Psychomimetics

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=9644281163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9644281163&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2004.08.018

DO - 10.1016/j.neuropharm.2004.08.018

M3 - Article

C2 - 15567423

AN - SCOPUS:9644281163

VL - 47

SP - 1135

EP - 1145

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 8

ER -